History of Blood Transfusion
History of Blood Transfusion
History of Blood Transfusion
HISTORY OF BLOOD
TRANSFUSION
HAEM VI
MLH 406
Mrs. Sheila Allotey
16TH APRIL, 2024
ATU
26/05/24 HISTORY 2
Blood in History
China, 1000 BC
The soul was contained in the blood. ( Lev 17:11)
“As soon as the blood began to enter into his veins, he felt
...heat along his arm, and under his Arm pits…His pulse rose
presently, and soon after we observ’d a plentiful sweat over all his
face. His pulse varied extremely at this instant, and he complained
of a great pain in his kidneys, and that he was not well in the
stomach, and that he was ready to choak unless they gave him
his liberty…When he awakened…He made a great glass full of
urine, of a color as black, as if it had been mixed with the soot of
chimneys.”
James Blundell
Blood Typing
Sturli and DeCastello described the fourth blood group,
AB, in 1902.
Compatibility testing
Landsteiner pointed out the importance of his findings in
his original paper. (1900)
Anti-coagulation
Blundell had observed the need for rapid transfusion in
order to prevent coagulation.
Anti-coagulation
The Kimpton-Brown
transfusion apparatus was
commonly used before
citration. It consisted of a
paraffin-coated gradient glass
cylinder with a horizontal
side tube for suction. It was
in use until approximately 1918.
27
Preservation
Furthering the work of Lewisohn and Weil, Rous and Turner
developed a solution of salt, isocitrate and dextrose in order to
both anticoagulate and preserve blood.
Preservation
Blood Banks
During the Spanish Civil War, the Republican Army banked
9000 liters of blood later administered at casualty stations and
base hospitals.
Component Therapy
Additive Solutions
• Additive solutions are preserving solutions that are added to
RBCs after removal of the plasma with or without platelets.
• It provides nutrients needed to maintain the RBCs during storage.
• It helps to overcome the problem of high viscosity of RBC
concentrate during transfusion.
• Example – Saline Adenine Glucose Mannitol (SAGM)
• Advantages:
• - Extends storage of RBCs
• - Lowers viscosity of red cell concentrates for ease of transfusion.
• - Maximum amount of fresh plasma is harvested.
May 26, 2024 41
Additive solutions
• PAGGSM: phosphate-adenine-glucose-guanosine-
saline-mannitol;
• PAG3M: phosphate-adenine-glucose-guanosine-
gluconate-mannitol;
• E-Sol: Erythro-Sol;
• AS: additive solution.
May 26, 2024 42
Haemostasis
• Haemostasis is a term used to describe the control of bleeding,
formation of a clot, and in the time of healing, the resolution of
the clot and a return to normal.
• The process has 4 major components:
• 1. Vasoconstriction
• 2. Platelet plug
• 3. Clot formation
• 4. Dissolving the clot
• Vasoconstriction: Vascular constriction occurs in a damaged
blood vessel with a mascular wall. This means that the blood
vessel contracts or tightens to minimize further loss of blood.
May 26, 2024 47
Haemostasis
• Platelet plug: When there is an injury, thromboplastin is
released and in the presence of calcium ions, it combines
with prothrombin to thrombin, which in turn activates
platelets.
• Activated platelets amplify the response by activating
more platelets and fibrinogen stimulates their sticking
together as a soft plug that loosely blocks the wound,
dramatically slowing down bleeding.
May 26, 2024 48
Haemostasis
• Clot formation: Each clotting factor has in the meanwhile
been participating in the process, which is why it is called
the coagulation cascade.
• A mesh of insoluble fibrin is finally formed, resulting in a
platelet plug and so reaching the endpoint of the clot
formation.
• As the clot shrinks serum is exuded.
Clotting factors
• Blood coagulation is the culmination of a series of complex
reactions that bring about a fibrin clot.
• The clotting cascade has two pathways:
• i. the tissue factor pathway
• Ii. The contact activation pathway.
• This is followed by the common pathway, in which clotting
factor X, thrombin and fibrin are activated.
• Clotting factors circulate in the bloodstream in the form of
inactive precursors.
• With the exception of FV, FVIII and platelets, clotting factors
are relatively stable in stored blood.
• FV and FVIII levels in donated blood plasma are stable only
when frozen soon after collection to temperatures below -25ºC
26/05/24 50
Arigato
gozaimashita!
That’s all folks….. Thank you!
Spaciba !
Merci!
ANY QUESTIONS?